317 related articles for article (PubMed ID: 21068435)
1. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort.
Bernaudin F; Verlhac S; Arnaud C; Kamdem A; Chevret S; Hau I; Coïc L; Leveillé E; Lemarchand E; Lesprit E; Abadie I; Medejel N; Madhi F; Lemerle S; Biscardi S; Bardakdjian J; Galactéros F; Torres M; Kuentz M; Ferry C; Socié G; Reinert P; Delacourt C
Blood; 2011 Jan; 117(4):1130-40; quiz 1436. PubMed ID: 21068435
[TBL] [Abstract][Full Text] [Related]
2. Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia.
Bernaudin F; Verlhac S; Arnaud C; Kamdem A; Vasile M; Kasbi F; Hau I; Madhi F; Fourmaux C; Biscardi S; Epaud R; Pondarré C
Blood; 2015 Mar; 125(10):1653-61. PubMed ID: 25533032
[TBL] [Abstract][Full Text] [Related]
3. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.
Buchanan ID; James-Herry A; Osunkwo I
J Pediatr Hematol Oncol; 2013 Oct; 35(7):543-6. PubMed ID: 23211694
[TBL] [Abstract][Full Text] [Related]
4. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.
Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B
Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812
[TBL] [Abstract][Full Text] [Related]
5. Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study.
Sommet J; Alberti C; Couque N; Verlhac S; Haouari Z; Mohamed D; François M; Missud F; Holvoet L; Elmaleh M; Ithier G; Denjean A; Elion J; Baruchel A; Benkerrou M
Br J Haematol; 2016 Mar; 172(6):966-77. PubMed ID: 26728571
[TBL] [Abstract][Full Text] [Related]
6. Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.
Bernaudin F; Verlhac S; Peffault de Latour R; Dalle JH; Brousse V; Petras E; Thuret I; Paillard C; Neven B; Galambrun C; Divialle-Doumdo L; Pondarré C; Guitton C; Missud F; Runel C; Jubert C; Elana G; Ducros-Miralles E; Drain E; Taïeb O; Arnaud C; Kamdem A; Malric A; Elmaleh-Bergès M; Vasile M; Leveillé E; Socié G; Chevret S;
JAMA; 2019 Jan; 321(3):266-276. PubMed ID: 30667500
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities.
Bernaudin F; Verlhac S; Arnaud C; Kamdem A; Hau I; Leveillé E; Vasile M; Kasbi F; Madhi F; Fourmaux C; Biscardi S; Gluckman E; Socié G; Dalle JH; Epaud R; Pondarré C
Blood; 2016 Apr; 127(14):1814-22. PubMed ID: 26851292
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.
Bishop S; Matheus MG; Abboud MR; Cane ID; Adams RJ; Jackson SM; Kalpatthi R
Blood Cells Mol Dis; 2011 Aug; 47(2):125-8. PubMed ID: 21724428
[TBL] [Abstract][Full Text] [Related]
9. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
[TBL] [Abstract][Full Text] [Related]
10. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
[TBL] [Abstract][Full Text] [Related]
11. Sickle cell anemia: intracranial stenosis and silent cerebral infarcts in children with low risk of stroke.
Arkuszewski M; Krejza J; Chen R; Ichord R; Kwiatkowski JL; Bilello M; Zimmerman R; Ohene-Frempong K; Melhem ER
Adv Med Sci; 2014 Mar; 59(1):108-13. PubMed ID: 24797985
[TBL] [Abstract][Full Text] [Related]
12. [Screening of cerebral vasculopathy in sickle cell anemia children using transcranial Doppler].
Dorie A; Guindo A; Saro YS; Touré BA; Fané B; Dembelé AK; Diallo DA
Arch Pediatr; 2015 Mar; 22(3):260-6. PubMed ID: 25636211
[TBL] [Abstract][Full Text] [Related]
13. Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study.
Seibert JJ; Glasier CM; Kirby RS; Allison JW; James CA; Becton DL; Kinder DL; Cox KS; Flick EL; Lairry F; Jackson JF; Graves RA
Pediatr Radiol; 1998 Mar; 28(3):138-42. PubMed ID: 9561529
[TBL] [Abstract][Full Text] [Related]
14. Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes.
Jordan LC; Roberts Williams DO; Rodeghier MJ; Covert Greene BV; Ponisio MR; Casella JF; McKinstry RC; Noetzel MJ; Kirkham FJ; Meier ER; Fuh B; McNaull M; Sarnaik S; Majumdar S; McCavit TL; DeBaun MR
Am J Hematol; 2018 Jun; 93(6):760-768. PubMed ID: 29520844
[TBL] [Abstract][Full Text] [Related]
15. Missed Opportunities for Transcranial Doppler Screening Among Children With Sickle Cell Disease.
Reeves SL; Fullerton HJ; Cohn LM; Dombkowski KJ; Boulton ML; Braun TM; Lisabeth LD
Clin Pediatr (Phila); 2016 Oct; 55(12):1093-9. PubMed ID: 26538586
[TBL] [Abstract][Full Text] [Related]
16. Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study.
Green NS; Munube D; Bangirana P; Buluma LR; Kebirungi B; Opoka R; Mupere E; Kasirye P; Kiguli S; Birabwa A; Kawooya MS; Lubowa SK; Sekibira R; Kayongo E; Hume H; Elkind M; Peng W; Li G; Rosano C; LaRussa P; Minja FJ; Boehme A; Idro R
BMC Pediatr; 2019 Oct; 19(1):381. PubMed ID: 31651270
[TBL] [Abstract][Full Text] [Related]
17. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
Rankine-Mullings A; Reid M; Soares D; Taylor-Bryan C; Wisdom-Phipps M; Aldred K; Latham T; Schultz WH; Knight-Madden J; Badaloo A; Lane A; Adams RJ; Ware RE
Br J Haematol; 2021 Nov; 195(4):612-620. PubMed ID: 34291449
[TBL] [Abstract][Full Text] [Related]
18. Cerebral Infarcts and Vasculopathy in Tanzanian Children With Sickle Cell Anemia.
Jacob M; Saunders DE; Sangeda RZ; Ahmed M; Tutuba H; Kussaga F; Musa B; Mmbando B; Slee AE; Kawadler JM; Makani J; Kirkham FJ
Pediatr Neurol; 2020 Jun; 107():64-70. PubMed ID: 32111561
[TBL] [Abstract][Full Text] [Related]
19. Big strokes in small persons.
Adams RJ
Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439
[TBL] [Abstract][Full Text] [Related]
20. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease.
Wang WC; Gallagher DM; Pegelow CH; Wright EC; Vichinsky EP; Abboud MR; Moser FG; Adams RJ
J Pediatr Hematol Oncol; 2000; 22(4):335-9. PubMed ID: 10959904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
